Today’s recruitment shortages and access to remote research sites pose a challenge in rare disease research — but Cerba means certainty. Together, we can shape and advance your complex trial by leveraging Cerba HealthCare patient databases and biorepositories spanning five continents. AI-driven access to demographically rich data and industry-leading laboratories save you time and effort, enabling your project to move forward.

Patients screened 28,496 Patients screened
Sites 4,865 Sites
Countries 62 Countries

24%

of our pediatric trials focus on rare diseases

34%

of trials in rare diseases are multiple myeloma trials

12%

of trials in rare diseases are leukemia trials

Acute myeloid leukemia
Acute lymphoblastic leukemia
Chronic lymphocytic leukemia

Enhance your research with patient- and data-driven insights

We offer a broad continuum of services and capabilities for research into rare diseases, particularly cancers. Get the help you need with: